What is DermaSensor?
DermaSensor specializes in innovative skin cancer detection technology, employing AI-driven precision to enhance diagnostics and screenings for better patient outcomes. The company's FDA cleared device allows healthcare providers to non-invasively assess suspicious skin lesions quickly and accurately, leading to more timely referrals to dermatology. The technology is suitable for various medical practices including internal medicine, family medicine, and medical aesthetics, catering to a wide range of healthcare professionals. DermaSensor aims to improve the clinical confidence of doctors while streamlining skin cancer detection services at the point of care.
How much funding has DermaSensor raised?
DermaSensor has raised a total of $16M across 1 funding round:
Series B
$16M
Series B (2025): $16M with participation from GenHenn Capital, Kern Venture Group, and Pier 70 Ventures
Key Investors in DermaSensor
GenHenn Capital
GenHenn Capital is a venture capital firm focused on investing in early-stage life sciences, healthcare, and biotech companies. They provide capital and strategic guidance to help scale high-impact solutions.
Kern Venture Group
Kern Venture Group is a venture capital firm that provides startups with capital, a diverse network, and valuable experience, particularly in early-stage to Series B investments, aiming to stimulate rural economies.
Pier 70 Ventures
Pier 70 Ventures invests in impact-driven technologies, particularly in healthcare, providing capital, mentorship, and access to a global network to accelerate high-growth sustainable companies.
What's next for DermaSensor?
With the infusion of major strategic investment, DermaSensor is poised for accelerated growth and technological advancement. The company's focus on AI-driven diagnostics for skin cancer detection positions it at the forefront of medical technology innovation. This capital infusion is anticipated to support the scaling of its operations, further research and development into its AI algorithms, and broader market penetration. DermaSensor's commitment to enhancing clinical confidence and streamlining point-of-care diagnostics suggests a strategic expansion into new healthcare verticals and geographical markets, solidifying its position as a leader in the field.
See full DermaSensor company page
